Additionally, research has indicated that in childhood leukemia, the allele frequency of UGT1A1*6 was notably elevated in the hyperbilirubinemia cohort compared to the non-hyperbilirubinemia cohort, thereby heightening the likelihood of adverse outcomes (28). This evidence concerns the gene UGT1A1 and leukemia.